An open label, uncontrolled clinical trial of immunogenicity and safety of yellow fever vaccine in adults with chronic kidney disease as compared to immunocompetent
Amanda Caroline Ribeiro Sales, Camila de Melo Picone, Adriana de Souza Azevedo Soares, Sheila Maria Barbosa de Lima, Anna Nishiya, Pedro Henrique Theotonio de Mesquita Pacheco, Paula Keiko Sato, Camila Cristina Martini Rodrigues, Marta Heloisa Lopes, Amanda Nazareth Lara, Karina Takesaki Miyaji, Luiz Sérgio Azevedo, Bruno Caldin Silva, Lígia Camera Pierrotti, Ana Marli Christovam Sartori Vaccine
· Elsevier
· 2027-01-01
· DOI: 10.1016/j.vaccine.2026.129314
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Amanda Caroline Ribeiro Sales, Camila de Melo Picone, Adriana de Souza Azevedo Soares, Sheila Maria Barbosa de Lima, Anna Nishiya, Pedro Henrique Theotonio de Mesquita Pacheco et al. An open label, uncontrolled clinical trial of immunogenicity and safety of yellow fever vaccine in adults with chronic kidney disease as compared to immunocompetent. // Vaccine. – 2027. – DOI: 10.1016/j.vaccine.2026.129314. – URL: https://doi.org/10.1016/j.vaccine.2026.129314
Amanda Caroline Ribeiro Sales, Camila de Melo Picone, Adriana de Souza Azevedo Soares, Sheila Maria Barbosa de Lima, Anna Nishiya, Pedro Henrique Theotonio de Mesquita Pacheco, Paula Keiko Sato, Camila Cristina Martini Rodrigues, Marta Heloisa Lopes, Amanda Nazareth Lara, Karina Takesaki Miyaji, Luiz Sérgio Azevedo, Bruno Caldin Silva, Lígia Camera Pierrotti, & Ana Marli Christovam Sartori (2027). An open label, uncontrolled clinical trial of immunogenicity and safety of yellow fever vaccine in adults with chronic kidney disease as compared to immunocompetent. Vaccine. https://doi.org/10.1016/j.vaccine.2026.129314
Amanda Caroline Ribeiro Sales, et al. “An open label, uncontrolled clinical trial of immunogenicity and safety of yellow fever vaccine in adults with chronic kidney disease as compared to immunocompetent.” Vaccine, 2027. doi:10.1016/j.vaccine.2026.129314.
@article{Sales2027,
title = {An open label, uncontrolled clinical trial of immunogenicity and safety of yellow fever vaccine in adults with chronic kidney disease as compared to immunocompetent},
author = {Sales, Amanda Caroline Ribeiro and Picone, Camila de Melo and Soares, Adriana de Souza Azevedo and Lima, Sheila Maria Barbosa de and Nishiya, Anna and Pacheco, Pedro Henrique Theotonio de Mesquita and Sato, Paula Keiko and Rodrigues, Camila Cristina Martini and Lopes, Marta Heloisa and Lara, Amanda Nazareth and Miyaji, Karina Takesaki and Azevedo, Luiz Sérgio and Silva, Bruno Caldin and Pierrotti, Lígia Camera and Sartori, Ana Marli Christovam},
journal = {Vaccine},
year = {2027},
doi = {10.1016/j.vaccine.2026.129314},
url = {https://doi.org/10.1016/j.vaccine.2026.129314}
}
Clinical endpoints for trials of Strep A vaccines: report of two expert meetingsKimberly Davis, Kirsty Le Doare, Johan Vekemans, Pierre Gsell, Annelies Wilder-Smith, Annette Kraus, Somyoung Cho, Liesl Zühlke, Scott H. Wirth, Joselyn Rwebembera, James Marangou, Marco Cavaleri, Yasir Bin Nisar, Christopher J. Gregory, Chris Van Beneden, Shiranee Sriskandan, Edwin Asturias, Alma Fulurija, Jim Ackland, Andrea Beaton, Joshua Osowicki, Jonathan Carapetis, Jerome H. Kim, Andrew SteerVaccine
· Общественное здоровье, гигиена и профпатология
· 2027-01-01